---
schema_version: "secwatch.filing_event.v1"
accession: "0001479681-24-000008"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:49:37.967356+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nutex Health Q2 revenue up 29% to $76.1M; Adjusted EBITDA up 200% to $12.0M

## Summary
- Net loss attributable to Nutex of $0.4M vs $3.5M loss in Q2 2023; H1 net loss $0.7M vs $8.6M.
- Hospital division visits 41,208 in Q2 (+28% YoY); mature hospital revenue +13.2%.
- Adjusted EBITDA (attributable) $12.0M in Q2, up 200% YoY; H1 Adjusted EBITDA $16.6M (+159%).
- Operating cash flow of $16.3M in H1 2024; cash $40.8M, long-term debt $22.4M.
- Non-cash impairments of $3.5M assets and $3.2M goodwill; $3.1M gain on warrant liability.

## SEC filing metadata
- accession: 0001479681-24-000008
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000147968124000008/0001479681-24-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000147968124000008/nutx-20240808x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001479681-24-000008
- JSON: https://secwatch.observer/filing/0001479681-24-000008.json
- Plain text: https://secwatch.observer/filing/0001479681-24-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.